(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSIÇÕES PARA TRATAMENTO DE CÂNCERES ASSOCIADOS A MUTAÇÕES DE RAS E KRAS, E USO DE ANTAGONISTAS DE KRAS

Em AnáliseInvention PatentPCT · US2022045191

Application data

Number

112024005931

Type

Invention Patent

Filing

09/29/2022

Publication

07/16/2024

PCT

US2022045191

Progress at the INPI

  1. Filing09/29/22
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 09/29/2022. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 09/30/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

TRUETIVA, INC.

US

Inventors

P. K. (pessoa física)

US

Technical data

Priority claims

US

17/449,275 · 09/29/2021

Abstract

ANTAGONISTAS DE KRAS.Compostos capazes de se ligarem e inibirem a atividade da proteína RAS são descritos neste pedido juntamente com composições e métodos úteis para o tratamento de doenças relacionadas à proteína RAS, como, por exemplo, câncer.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Adição na publicação

#15.35

Referente à RPI 2793 de 16/07/2024, quanto ao item (54)

09/30/2025

RPI 2856

Notificação de entrada na fase nacional - PCT

#1.3

07/16/2024

RPI 2793

Alteração de dados cadastrais

#1.1

04/09/2024

RPI 2779

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.